TABLE 2.
Clinical outcomes according to treatment received
| Variable | mOS (m) | 95 % CI | p value |
|---|---|---|---|
| Any adjuvant therapy | 16.4 | 14–21 | 0.0007 |
| No adjuvant therapy | 6.3 | 1.5–10.1 | |
| Type of adjuvant therapy | |||
| CT | 21.5 | 13.4–24.6 | 0.76 |
| CRT | 16.8 | 13.9–23.1 | |
| Lymph node statusa | |||
| Negative | 24 | 19.8–34.2 | 0.0003 |
| Positive | 13.8 | 10.9–15.2 | |
| Resection margin status | |||
| Negative (R0) | 16.6 | 13.4–20.1 | 0.36 |
| Positive (R1)ab | 16.4 | 13.8–23.6 | |
| Tumor size (cm) | |||
| <3 | 16.4 | 12.1–21 | 0.0924 |
| ≥3 | 16.8 | 13.7–24 | |
| Tumor differentiation | |||
| Well-moderate | 15.2 | 8.7–25.6 | 0.54 |
| Poor | 16.4 | 13.9–23 | |
| Sex | |||
| Male | 17.1 | 13.9–24.3 | 0.55 |
| Female | 16.4 | 12.2–23.1 | |
| Age (years) | |||
| <70 | 20.4 | 13.7–29.9 | 0.0514 |
| ≥70 | 15.2 | 13.6–18.3 |
Bold values are statistically significant
In patients receiving adjuvant therapy
Microscopically positive